An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19366825

Clin. Cancer Res. 2009 May 1 15 9 3172-6

Download in:

View as

General Info

PMID
19366825